Assessment of Oxidative Stress Biomarkers (MDA, TAC, SOD) in Type 2 Diabetes Mellitus Patients and their Correlation with HbA1c Levels
DOI:
https://doi.org/10.55544/jrasb.4.6.5Keywords:
Type 2 Diabetes Mellitus, Oxidative Stress, Malondialdehyde (MDA), Total Antioxidant Capacity (TAC), Superoxide Dismutase (SOD), HbA1c, Biomarkers, Glycaemic Control, Antioxidants, Diabetic ComplicationsAbstract
Type 2 Diabetes Mellitus (T2DM) is closely linked with increased oxidative stress due to chronic hyperglycaemia, which disrupts the balance between reactive oxygen species (ROS) and antioxidant defences. This study assesses key oxidative stress biomarkers—malondialdehyde (MDA), total antioxidant capacity (TAC), and superoxide dismutase (SOD)—in patients with T2DM and examines their correlation with glycated haemoglobin (HbA1c) levels. A cross-sectional design was employed, involving T2DM patients and age-matched healthy controls. Blood samples were analysed using standard biochemical methods to quantify oxidative stress markers and glycaemic control parameters. Results showed significantly elevated MDA levels in T2DM patients, reflecting increased lipid peroxidation and oxidative damage. Conversely, TAC and SOD activities were markedly reduced compared to the control group, indicating compromised antioxidant defence systems. Correlation analysis demonstrated a strong positive association between MDA and HbA1c, while TAC and SOD showed significant negative correlations with HbA1c. These findings suggest that poor glycaemic control exacerbates oxidative stress, contributing to diabetes-related complications. Monitoring oxidative stress biomarkers alongside HbA1c may enhance early identification of metabolic imbalance and support targeted therapeutic strategies. The study highlights the importance of antioxidant-focused interventions to improve clinical outcomes in T2DM patients.
Downloads
References
ADA. (2023). Standards of Medical Care in Diabetes. American Diabetes Association.
Apak, R., et al. (2016). “Total antioxidant capacity assays.” TrAC Trends in Analytical Chemistry, 76, 25–45.
Baynes, J., & Thorpe, S. (1999). “Role of oxidative stress in diabetic complications.” Diabetes, 48(1), 1–9.
Brownlee, M. (2005). “The pathobiology of diabetic complications.” Diabetes, 54, 1615–1625.
Davi, G., et al. (2005). “Oxidative stress and diabetic complications.” Circulation, 115(2), 243–252.
Del Rio, D., Stewart, A., & Pellegrini, N. (2005). “A review of antioxidant assays.” Nutrition, Metabolism & Cardiovascular Diseases, 15, 316–328.
Evans, J., et al. (2002). “Oxidative stress and diabetic complications.” Diabetologia, 45(10), 1245–1255.
Forbes, J., & Cooper, M. (2013). “Mechanisms of diabetic complications.” Physiological Reviews, 93, 137–188.
Gavrelis, N., et al. (2019). “MDA levels and glycaemic control.” Clinical Biochemistry, 67, 32–39.
IDF. (2023). Global Diabetes Atlas.
Kesavulu, M., et al. (2001). “Lipid peroxidation and antioxidant status in diabetes.” Diabetes Research and Clinical Practice, 53, 33–39.
Maritim, A., Sanders, R., & Watkins, J. (2003). “Diabetes, oxidative stress, and antioxidants.” Journal of Biochemical and Molecular Toxicology, 17(1), 24–38.
Nita, M., & Grzybowski, A. (2016). “Oxidative stress in diabetes.” Journal of Diabetes Research, 2016, 1–13.
Pitocco, D., et al. (2010). “Oxidative stress and diabetes complications.” Journal of Endocrinological Investigation, 33, 1–9.
Yamamoto, M., et al. (2018). “Hyperglycaemia, oxidative stress, and HbA1c.” Redox Biology, 17, 295–302.
Yilmaz, N., et al. (2016). “Antioxidant levels and HbA1c.” Journal of Clinical Laboratory Analysis, 30, 123–128
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mr. Sukhi Ram, Mr. Ankush Gupta, Dr. Nafisul Hasan, Ms. Simran Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/jrasb
editor@jrasb.com or mailtojrasb@gmail.com | 
+91-8874396939
This work is licensed under a 